These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22901165)

  • 1. Loss of DBC2 expression is an early and progressive event in the development of lung adenocarcinoma.
    Dong W; Meng L; Shen HC; Du JJ
    Asian Pac J Cancer Prev; 2012; 13(5):2021-3. PubMed ID: 22901165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathologic features of the tumor budding in adenocarcinoma of the lung: tumor budding as an index to predict the potential aggressiveness.
    Yamaguchi Y; Ishii G; Kojima M; Yoh K; Otsuka H; Otaki Y; Aokage K; Yanagi S; Nagai K; Nishiwaki Y; Ochiai A
    J Thorac Oncol; 2010 Sep; 5(9):1361-8. PubMed ID: 20631633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
    Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
    J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological and molecular evidence indicating the independence of bronchioloalveolar components from other subtypes of human peripheral lung adenocarcinoma.
    Koga T; Hashimoto S; Sugio K; Yoshino I; Mojtahedzadeh S; Matsuo Y; Yonemitsu Y; Sugimachi K; Sueishi K
    Clin Cancer Res; 2001 Jun; 7(6):1730-8. PubMed ID: 11410513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of aquaporin 1, 3, and 5 expression in lung cancer cells to cellular differentiation, invasive growth, and metastasis potential.
    Machida Y; Ueda Y; Shimasaki M; Sato K; Sagawa M; Katsuda S; Sakuma T
    Hum Pathol; 2011 May; 42(5):669-78. PubMed ID: 21237499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor mutation and p53 overexpression during the multistage progression of small adenocarcinoma of the lung.
    Yoo SB; Chung JH; Lee HJ; Lee CT; Jheon S; Sung SW
    J Thorac Oncol; 2010 Jul; 5(7):964-9. PubMed ID: 20512074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchioloalveolar invasion in non-small cell lung cancer is associated with expression of transforming growth factor-β1.
    Imai K; Minamiya Y; Goto A; Nanjo H; Saito H; Motoyama S; Sato Y; Kudo S; Takashima S; Kawaharada Y; Kurihara N; Orino K; Ogawa J
    World J Surg Oncol; 2013 May; 11():113. PubMed ID: 23705641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung adenocarcinoma global profiling identifies type II transforming growth factor-beta receptor as a repressor of invasiveness.
    Borczuk AC; Kim HK; Yegen HA; Friedman RA; Powell CA
    Am J Respir Crit Care Med; 2005 Sep; 172(6):729-37. PubMed ID: 15976377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IMP3 expression is correlated with histologic grade of lung adenocarcinoma.
    Findeis-Hosey JJ; Yang Q; Spaulding BO; Wang HL; Xu H
    Hum Pathol; 2010 Apr; 41(4):477-84. PubMed ID: 20004948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DBC2/RhoBTB2 functions as a tumor suppressor protein via Musashi-2 ubiquitination in breast cancer.
    Choi YM; Kim KB; Lee JH; Chun YK; An IS; An S; Bae S
    Oncogene; 2017 May; 36(20):2802-2812. PubMed ID: 27941885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of the characteristics in recurrence and metastasis between bronchioloalveolar carcinoma and other lung adenocarcinomas].
    Zhong XJ; Li DT; Li XL; Mu DB; Zhang XG; Luo JY
    Ai Zheng; 2007 Jul; 26(7):785-9. PubMed ID: 17626761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased cytoplasmic S100A6 expression is associated with pulmonary adenocarcinoma progression.
    Ishii A; Suzuki M; Satomi K; Kobayashi H; Sakashita S; Kano J; Pei Y; Minami Y; Ishikawa S; Noguchi M
    Pathol Int; 2009 Sep; 59(9):623-30. PubMed ID: 19712129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT3 expression in activating EGFR-driven adenocarcinoma of the lung.
    Takata S; Takigawa N; Segawa Y; Kubo T; Ohashi K; Kozuki T; Teramoto N; Yamashita M; Toyooka S; Tanimoto M; Kiura K
    Lung Cancer; 2012 Jan; 75(1):24-9. PubMed ID: 21684622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (Makimoto Y; Nabeshima K; Iwasaki H; Miyoshi T; Enatsu S; Shiraishi T; Iwasaki A; Shirakusa T; Kikuchi M
    Histopathology; 2005 Jun; 46(6):677-84. PubMed ID: 15910599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the mammalian target of rapamycin: a novel biomarker for poor survival in resected early stage non-small cell lung cancer.
    Dhillon T; Mauri FA; Bellezza G; Cagini L; Barbareschi M; North BV; Seckl MJ
    J Thorac Oncol; 2010 Mar; 5(3):314-9. PubMed ID: 20093977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophils promote aerogenous spread of lung adenocarcinoma with bronchioloalveolar carcinoma features.
    Wislez M; Antoine M; Rabbe N; Gounant V; Poulot V; Lavolé A; Fleury-Feith J; Cadranel J
    Clin Cancer Res; 2007 Jun; 13(12):3518-27. PubMed ID: 17575214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological characteristics of primary lung adenocarcinoma predominantly composed of goblet cells in surgically resected cases.
    Ichinokawa H; Ishii G; Nagai K; Yoshida J; Nishimura M; Hishida T; Suzuki K; Ochiai A
    Pathol Int; 2011 Jul; 61(7):423-9. PubMed ID: 21707846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advance in pulmonary adenocarcinoma with micropapillary pattern].
    ZHANG J; LIANG ZY; LIU TH
    Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):202-5. PubMed ID: 21575400
    [No Abstract]   [Full Text] [Related]  

  • 19. Bronchioloalveolar carcinoma (lepidic growth) component is a more useful prognostic factor than lymph node metastasis.
    Anami Y; Iijima T; Suzuki K; Yokota J; Minami Y; Kobayashi H; Satomi K; Nakazato Y; Okada M; Noguchi M
    J Thorac Oncol; 2009 Aug; 4(8):951-8. PubMed ID: 19543119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic alterations of tumor suppressor ING1 in human non-small cell lung cancer.
    Luo ZG; Tang H; Li B; Zhu Z; Ni CR; Zhu MH
    Oncol Rep; 2011 Apr; 25(4):1073-81. PubMed ID: 21286670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.